18 Mar 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/remedy-pharmaceuticals-secures-key-us-patent-allowance-for-cirara-in-treating-large-hemispheric-infarction-including-wake-up-strokes-302401375.html
29 Jan 2025
// FDA
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-29-2025-5490.pdf
25 Nov 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/11/25/2986515/0/en/Eton-Pharmaceuticals-Announces-Acquisition-of-U-S-Rights-to-Amglidia-Glyburide-Oral-Suspension.html
01 Oct 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/remedy-pharmaceuticals-phase-3-trial-in-large-lesion-stroke-patients-demonstrates-statistically-significant-effect-at-one-year-302260511.html
30 May 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/remedy-pharmaceuticals-gets-rights-to-acute-stroke-drug-back-from-biogen-announces-clinically-meaningful-and-statistically-significant-results-from-pre-specified-subgroup-and-post-hoc-analyses-of-phase-3-study-302157095.html
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/sugarmds-llc-issues-voluntary-nationwide-recall-advanced-glucose-support-supplements-capsules-due